SCHEMBL8302616

SCHEMBL8302616

Nc1cccc(/N=C/c2cc(/N=N\c3ccccc3Cl)ccc2O)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 10/20 0.60
KMT2A Q03164 7/20 0.60
ALDH1A1 P00352 6/20 0.60
MEN1 O00255 6/20 0.60
POLB P06746 5/20 0.60
NPC1 O15118 3/20 0.60
RAB9A P51151 3/20 0.60
NPSR1 Q6W5P4 3/20 0.60
LMNA P02545 3/20 0.60
TDP1 Q9NUW8 3/20 0.60
L3MBTL1 Q9Y468 3/20 0.60
MCL1 Q07820 3/20 0.54
THRB P10828 3/20 0.54
SMN1; SMN2 Q16637 4/20 0.46
KDM4E B2RXH2 1/20 0.45
HTT P42858 1/20 0.45
HPGD P15428 2/20 0.39
XBP1 P17861 1/20 0.39
CA12 O43570 1/20 0.39
CA2 P00918 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10725707 0.76 MAPT (1.00) MAPTKMT2AALDH1A1MEN1POLB
SCHEMBL11418963 0.75 SIRT2 (0.62) MAPTKMT2AALDH1A1MEN1KDM4E
SCHEMBL11418959 0.75 SIRT2 (0.62) MAPTKMT2AALDH1A1MEN1KDM4E
SCHEMBL8292171 0.75 MAPT (0.61) MAPTKMT2AALDH1A1MEN1POLB
SCHEMBL12416873 0.74 MAPT (0.57) MAPTKMT2AALDH1A1MEN1POLB
SCHEMBL11322819 0.70 CYP3A4 (0.53) MAPTKMT2AALDH1A1MEN1NPC1
SCHEMBL11646880 0.69 TDP1 (0.50) MAPTKMT2AALDH1A1MEN1NPC1
SCHEMBL11647119 0.69 TDP1 (0.50) MAPTKMT2AALDH1A1MEN1NPC1
SCHEMBL10623952 0.69 MAPT (0.70) MAPTKMT2AALDH1A1MEN1POLB
SCHEMBL17018635 0.68 MAOB (0.56) MAPTKMT2AALDH1A1MEN1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005037779-A2 NOVEL DIPEPTIDYL PEPTIDASE IV INHIBITORS USED FOR FUNCTIONALLY INFLUENCING DIFFERENT CELLS AND TREATING IMMUNOLOGICAL, INFLAMMATORY, NEURONAL, AND OTHER DISEASES IMTM GMBH (DE) 2005-04-28 WO disclosed